ABA Pain Medicine study materials
ABA Pain Medicine study resources

Behavioral Change in Advanced Dementia

ABA Pain Medicine · Put your knowledge to work in context.

All case studies

Behavioral Change in Advanced Dementia

84-year-old woman with advanced Alzheimer disease (MMSE 9) in a nursing home develops new aggression, moaning during transfers, and disrupted sleep. She cannot report pain. Her daughter says she 'seems uncomfortable' but staff think she is 'just demented.' She takes donepezil 10 mg, memantine 20 mg, and recently started oxycodone 5 mg every 6 hours for knee osteoarthritis. Exam: dry mucous membranes, distended bladder, hard stool in rectum, right knee crepitus with guarding. Pain score unavailable. The medical director asks whether to increase oxycodone.

1. How would you determine whether her behavioral change is pain, delirium, or both?

Read the worked answer

I would start by treating the behavior as a possible communication of distress, not as 'just dementia.' Obtain a careful history from staff and daughter about timing, triggers (transfers, dressing, toileting), facial expression, guarding, and response to analgesics. Use an observational tool such as PAINAD or the Abbey Pain Scale, scored before and after an activity and after a time-limited analgesic trial. At the same time, screen for delirium: acute onset, fluctuating attention, and disorientation. Her dry mucous membranes, distended bladder, and hard stool suggest constipation and urinary retention, both of which can cause agitation and are worsened by oxycodone. Check a bladder scan, review the bowel regimen, and look for infection, dehydration, dental pain, and pressure injuries. A negative pain score on a tool does not rule out pain in advanced dementia; the pattern across activities matters. I would not increase oxycodone until reversible causes are addressed.

2. What would you recommend for treatment, including pharmacologic and nonpharmacologic measures?

Read the worked answer

First, stop the oxycodone temporarily or reduce it, because it may be contributing to delirium and constipation. Treat the urinary retention and disimpaction, hydrate, and start a scheduled bowel regimen if an opioid is continued. For knee osteoarthritis, use scheduled acetaminophen up to 3 g/day, topical diclofenac if renal function permits, physical therapy, repositioning, and a warm pack before transfers. If pain behaviors persist after these measures, a low-dose opioid trial (e.g., oxycodone 2.5 mg every 6 hours) with clear pre- and post-dosing PAINAD scores is reasonable, but only with a bowel regimen and monitoring for sedation. Avoid anticholinergics and unnecessary antipsychotics; if delirium persists, evaluate for causes rather than sedating. Nonpharmacologic care-consistent caregivers, familiar objects, sleep hygiene, and gentle mobilization-is as important as medication.

3. How would you document and communicate the plan to the nursing staff?

Read the worked answer

Document the assessment, the confounders identified, the observational tool scores before and after intervention, and the rationale for not simply escalating opioids. Write an order set that specifies scheduled acetaminophen, bowel and bladder care, and a time-limited opioid trial with parameters for holding the dose if sedation or confusion worsens. Use a handoff to the nursing staff that describes what pain behaviors look like for this patient and what to do when they occur-for example, reposition, offer toileting, and score with PAINAD before calling for a PRN. Avoid labeling her as drug-seeking or demented. Arrange a family meeting to align goals and explain that comfort and function are the targets. Reassess in 24–48 hours and revise the plan based on response.